Exhibit 99.1
M FUND, INC.
PARTICIPATION AGREEMENT
WITH
THE LINCOLN LIFE & ANNUITY COMPANY OF NEW YORK
THIS AGREEMENT, made and entered into this 1st day of May, 2003, by
and among M FUND, INC., a corporation organized and existing under the laws of
the State of Maryland (the "Fund"), M FINANCIAL INVESTMENT ADVISERS, INC., a
corporation organized and existing under the laws of the State of Colorado (the
"Adviser") and The LINCOLN LIFE & ANNUITY COMPANY OF NEW YORK, a life insurance
company organized and existing under the laws of the State of New York (the
"Company"), on its own behalf and on behalf of each separate account of the
Company identified herein.
WHEREAS, the Fund is a series-type mutual fund offering shares of
beneficial interest (the "Fund shares") consisting of one or more series
("Series") of shares ("Series shares"), each such Series share representing an
interest in a particular managed portfolio of securities and other assets; and
WHEREAS, the Fund was established for the purpose of serving as an
investment vehicle for insurance company separate accounts supporting variable
annuity contracts and variable life insurance policies to be offered by
insurance companies; and
WHEREAS, the Company desires that the Fund serve as an investment
vehicle for certain separate account(s) of the Company;
WHEREAS, the Adviser is duly registered as an investment adviser
pursuant to the Investment Advisers Act of 1940;
NOW, THEREFORE, in consideration of their mutual promises, the Fund,
the Adviser, and the Company agree as follows:
ARTICLE I. ADDITIONAL DEFINITIONS
1.1. "Account" -- each separate account of the Company described more
specifically in Schedule 1 to this Agreement (as may be amended from time to
time).
1.2. "Business Day" -- each day that the New York Stock Exchange is
open for trading.
1.3. "Code" -- the Internal Revenue Code of 1986, as amended.
1.4. "Contracts" -- the class or classes of variable annuity contracts
and variable life insurance policies issued by the Company and described more
specifically on Schedule 2 to this Agreement (as may be amended from time to
time).
1.5. "Contract Owners" -- the owners of the Contracts, as
distinguished from all Product Owners.
1.6. "NASD" -- National Association of Securities Dealers, Inc.
1.7. "Participating Account" -- a separate account investing all or a
portion of its assets in the Fund, including the Account.
1.8. "Participating Insurance Company" -- any insurance company
investing in the Fund on its behalf or on behalf of a Participating Account,
including the Company.
1.9. "Products" -- variable annuity contracts and variable life
insurance policies supported by Participating Accounts investing assets
attributable thereto in the Fund, including the Contracts.
1.10. "Product Owners" -- owners of Products, including Contract
Owners.
1.11. "Prospectus" -- with respect to the Fund shares or a class of
Contracts, each version of the definitive prospectus therefor or supplement
thereto filed with the Securities and Exchange Commission (SEC) pursuant to Rule
497 under the 1933 Act. With respect to any provision of this Agreement
requiring a party to take action in accordance with a Prospectus, such reference
thereto shall be deemed to be to the version last so filed prior to the taking
of such action. For purposes of Section 4.6 and Article VIII, the term
"Prospectus" shall include any statement of additional information incorporated
therein.
1.12. "Registration Statement" -- with respect to the Fund shares or a
class of Contracts, the registration statement filed with the SEC to register
the securities issued thereby under the 1933 Act, or the most recently filed
amendment thereto, in either case in the form in which it was declared or became
effective. The Contracts Registration Statement (if any) is described more
specifically on Schedule 2 to this Agreement. The Fund Registration Statement
was filed on Form N-1A (File No. 33-95472).
1.13. "1940 Act Registration Statement" -- with respect to the Fund or
the Account, the registration statement filed with the SEC to register such
person as an investment company under the 1940 Act, or the most recently filed
amendment thereto. Each Account's 1940 Act Registration Statement (if any) is
described more specifically on Schedule 2 to this Agreement. The Funds 1940 Act
Registration Statement was filed on Form N-1A (File No. 811-9082).
2
1.14. "Statement of Additional Information" -- with respect to the
Fund or a class of Contracts, each version of the definitive statement of
additional information or supplement thereto filed with the SEC pursuant to Rule
497 under the 0000 Xxx.
1.15. "SEC" -- the Securities and Exchange Commission.
1.16. "1933 Act" -- the Securities Act of 1933, as amended.
1.17. "1940 Act" -- the Investment Company Act of 1940, as amended.
ARTICLE II. SALE OF FUND SHARES
2.1. The Fund shall make shares of those Series listed on Schedule 3
to this Agreement available for purchase by the Company on its own behalf or on
behalf of the Account, such purchases to be effected at net asset value in
accordance with Section 2.3 of this Agreement. Notwithstanding the foregoing,
(i) Fund Series in existence now or that may be established in the future and
not listed on Schedule 3 will be made available to the Company only as the
Adviser may so provide, and (ii) the Board of Directors of the Fund (the "Fund
Board") may suspend or terminate the offering of Fund shares of any Series or
class thereof, if such action is required by law or by regulatory authorities
having jurisdiction or if, in the sole discretion of the Fund Board acting in
good faith and in light of its fiduciary duties under federal and any applicable
state laws, suspension or termination is necessary or in the best interests of
the shareholders of any Series (it being understood that "shareholders" for this
purpose shall mean Product Owners).
2.2. The Fund shall redeem, at the Company's request, any full or
fractional shares of the Fund held by the Company on behalf of the Account, such
redemptions to be effected at net asset value in accordance with Section 2.3 of
this Agreement. Notwithstanding the foregoing, the Fund may delay redemption of
Fund shares of any Series to the extent permitted by the 1940 Act or any rules,
regulations or orders thereunder.
2.3. PURCHASE AND REDEMPTION PROCEDURES
(a) The Fund hereby appoints the Company as an agent of the Fund
for the limited purpose of receiving purchase and redemption requests for
shares of the Fund based on allocations of amounts to the Account or
subaccounts thereof under the Contracts and other transactions arising out
of the Contracts. Receipt of any such request (or relevant transactional
information therefor) on any Business Day by the Company as such limited
agent of the Fund prior to 4:00 p.m. New York Time ("NYT") shall constitute
receipt by the Fund on that same Business Day, provided that the Fund
receives notice of such request by 10:00 am NYT on the next following
Business Day.
(b) The Fund will confirm receipt of each trade (ending share
balance by Account and Fund) and these confirmations will be made available
to Company by 1:00
3
pm New York time on the day the Fund is properly notified of the trade,
using a mutually agreed upon format. The Company, which in addition to
being a life insurance company is a broker/dealer and member of the NASD,
shall pay for the shares on the same day that it places an order with the
Fund to purchase those Fund shares for an Account. Payment for Fund shares
will be made by each Account or the Company in Federal Funds to the Fund,
prior to the close of the Federal Reserve wire system on the day the Fund
is properly notified of the purchase order for shares. If payment is not
received by the Fund on the same Business Day, the Company shall, upon
Fund's request, promptly reimburse the Fund for any charges, costs, fees,
interest or other expenses incurred in connection with advances, borrowing
and overdrafts. If the banking system is closed, payment will be initiated
the next day the banking system is open for business. The Fund will confirm
receipt of each trade and these confirmations will be received on time,
such funds will be invested, and shares purchased thereby will be issued,
as soon as practicable.
Payment for shares redeemed by each Account or the Company will be made in
Federal Funds to the Company, prior to the close of the Federal Reserve
wire system on the same day the Fund is properly notified of the redemption
order or shares, except that the Fund reserves the right to delay payment
of redemption proceeds as permitted under Section 22(e) of the 0000 Xxx. If
payment is not received by Company the same Business Day, the Fund shall,
upon Company's request, promptly reimburse the Company for any charges,
costs, fees, interest or other expenses incurred in connection with
advances, borrowing, and overdrafts. If the banking system is closed,
payment will be initiated the next day the banking system is open for
business. Neither the Fund nor the Adviser shall bear any responsibility
whatsoever for the proper disbursement or crediting of redemption proceeds
if securities are redeemed; the Company alone shall be responsible for such
action.
(c) Any purchase or redemption requests for Fund shares that do
not result directly from transactions relating to the Contracts or the
Account shall be effected at the net asset value per share next determined
after the Fund's receipt of such request, provided that, in the case of a
purchase request, payment for Fund shares so requested is received by the
Fund in federal funds prior to close of business for determination of such
value, as defined from time to time in the Fund Prospectus.
2.4. The Fund shall use its best efforts to calculate and make the net
asset value per share for each Series available to the Company by 5:30 p.m. NYT
each Business Day, and in any event, as soon as reasonably practicable after the
net asset value per share for such Series is calculated, and shall calculate
such net asset value in accordance with the Fund Prospectus. Neither the Fund,
any Series, the Adviser, nor any of their affiliates shall be liable for any
information provided to the Company pursuant to this Agreement to the extent
such information is based on incorrect information supplied by the Company or
any other Participating Insurance Company or Qualified Person (as defined in
Section 2.8 of this Agreement) to the Fund or the Adviser.
4
In the event that Fund is unable to meet 5:30 p.m. time stated herein,
it shall provide additional time for the Company to place orders for the
purchase and redemption of shares. Such additional time shall be equal to the
additional time which the Fund takes to make the net asset value available to
the Company. Also, the Fund will notify the Company when and if the Fund is
unable to provide the net asset value per share by 5:30 p.m. NYT. If the Fund
provides the Company with materially incorrect share net asset value information
through no fault of the Company, the Company on behalf of the Separate Accounts,
shall be entitled to an adjustment to the number of shares purchased or redeemed
to reflect the correct share net asset value. Any material error in the
calculation of net asset value per share, dividend or capital gain information
shall be reported promptly upon discovery to the Company. Neither the Company,
nor any of its affiliates shall be liable for any information provided to the
Fund or its affiliates or designees pursuant to this Agreement which information
is based on incorrect information supplied by the Fund to the Company. In the
event of any material error in the calculation or communication of net asset
value, dividends or capital gain information or any delay in the communication,
the responsible party or parties shall reimburse the Company for any losses or
reasonable costs incurred as a result of the error or delay, including but not
limited to, amounts needed to make contract owners whole and reasonable
administrative costs necessary to correct the error.
2.5. The Fund shall furnish notice to the Company (by fax, or
telephone followed by written confirmation) as soon as reasonably practicable of
any income dividends or capital gain distributions payable on any Series shares.
The Company, on its behalf and on behalf of the Account, hereby elects to
receive all such dividends and distributions as are payable on any Series shares
in the form of additional shares of that Series. The Company reserves the right,
on its behalf and on behalf of the Account, to revoke this election and to
receive all such dividends and distributions in cash. The Fund shall notify the
Company promptly of the number of Series shares so issued as payment of such
dividends and distributions.
2.6. Issuance and transfer of Fund shares shall be by book entry only.
Stock certificates will not be issued to the Company or the Account. Purchase
and redemption orders for Fund shares shall be recorded in an appropriate ledger
for the Account or the appropriate subaccount of the Account.
2.7. (a) The Company may withdraw the Account's investment in the Fund
or a Series of the Fund only: (i) as necessary to facilitate Contract Owner
requests; (ii) upon a determination by a majority of the Fund Board, or a
majority of disinterested Fund Board members, that an irreconcilable
material conflict exists among (x) the interests of all Product Owners or
(y) the interests of the Participating Insurance Companies investing in the
Fund; (iii) upon requisite vote of the Contract Owners having an interest
in the affected Series; (iv) as required by state and/or federal laws or
regulations or judicial or other legal precedent of general implication;
(v) upon sixty (60) days advance written notice; (vi) from a Series, upon a
change in the Portfolio Manager for that Series; or (vii) as permitted by
an order of the SEC pursuant to Section 26(b) of the 1940 Act.
5
(b) The Company shall not, without the prior written consent of
the Adviser (unless otherwise required by applicable law), solicit, induce
or encourage Contract Owners to change or modify the Fund or change the
Fund's investment adviser.
2.8. The Fund shall sell Fund shares only to Participating Insurance
Companies and their separate accounts and to persons or plans ("Qualified
Persons") that qualify to purchase and hold shares of the Fund under Section
817(h) of the Code. The Fund shall not sell Fund shares to any insurance
company, separate account or Qualified Person unless an agreement containing
provisions substantially similar to Articles II, V, and VII of this Agreement is
in effect to govern such sales (to the extent required in order to comply with
the "Exemptive Order" referred to in Section 7.1 below).
ARTICLE III. REPRESENTATIONS AND WARRANTIES
3.1. The Company represents and warrants that: (i) the Company is an
insurance company duly organized, validly existing under New York insurance law;
(ii) the Account is (or will be prior to the purchase by the Company of Fund
shares for the Account) a validly existing separate account, duly established
and maintained in accordance with applicable law; (iii) the Contracts will be
issued in compliance in all material respects with all applicable federal and
state laws; (iv) the Contracts currently are and at the time of issuance will be
treated as annuity contracts or life insurance policies, whichever is
appropriate, under applicable provisions of the Code; and (v) the Company and
the Account qualify (or will qualify prior to the purchase by the Company of
Fund shares for the Account) to purchase and hold shares of the Fund under
Section 817(h) of the Code.
3.2. The Fund represents and warrants that: (i) the Fund is a
corporation duly organized, validly existing and in good standing under Maryland
law; (ii) the Fund's 1940 Act Registration Statement has been filed with the SEC
in accordance with the provisions of the 1940 Act and the Fund is and shall
remain duly registered as an open-end management investment company thereunder;
(iii) the Fund Registration Statement has been declared effective by the SEC (or
will be declared effective before the sale by the Fund of its shares pursuant to
this Agreement); (iv) Fund shares sold pursuant to this Agreement have been duly
authorized for issuance in accordance with applicable law; (v) the Fund is and
shall remain qualified as a "regulated investment company" under Subchapter M of
the Code and is and shall remain in compliance with Section 817(h) of the Code;
(vi) the Fund's investment policies are in material compliance with any
investment restrictions set forth on Schedule 4 to this Agreement; and (vii) the
Fund does and will comply in all material respects with the 1940 Act. The Fund,
however, makes no representation as to whether any aspect of its operations
(including, but not limited to, fees and expenses and investment policies)
otherwise complies with the insurance laws or regulations of any state.
3.3. The Adviser represents and warrants that it is and will remain
registered in all material respects as an investment adviser under federal and
all applicable state securities
6
laws, and shall perform its obligations hereunder in compliance in all material
respects with any such applicable state and federal laws. The Adviser represents
that it will manage the Fund consistent with the Fund's investment objectives,
policies, and restrictions.
3.4. Each party represents that the execution and delivery of this
Agreement and the consummation of the transactions contemplated herein have been
duly authorized by all necessary corporate or trust action, as applicable, by
such party, and, when so executed and delivered, this Agreement will be the
valid and binding obligation of such party enforceable in accordance with its
terms.
3.5. The Fund represents and warrants that all of its directors,
officers, and employees dealing with the money and/or securities of the Fund are
and shall continue to be at all times covered by a blanket fidelity bond or
similar coverage for the benefit of the Fund in an amount not less than the
minimal coverage as required currently by Rule 17g-1 of the 1940 Act or related
provisions as may be promulgated from time to time. The aforesaid Bond shall
include coverage for larceny and embezzlement and shall be issued by a reputable
bonding company.
3.6. The Company represents and warrants that all of its directors,
officers, and employees dealing with the money and/or securities of the Fund are
and shall continue to be at all times covered by a blanket fidelity bond or
similar coverage for the benefit of the Fund, in an amount not less than the
minimal coverage as required currently by entities subject to the requirements
of Rule 17g-1 of the 1940 Act or related provisions as may be promulgated from
time to time. The aforesaid Bond shall include coverage for larceny and
embezzlement and shall be issued by a reputable bonding company.
ARTICLE IV. FILINGS, INFORMATION AND EXPENSES
4.1. The Fund shall amend the Fund Registration Statement and the
Fund's 1940 Act Registration Statement from time to time as required in order to
effect the continuous offering of Fund shares and to maintain the Fund's
registration under the 1940 Act for so long as Fund shares are sold. The Fund
shall file, register, qualify and obtain approval of the Fund shares for sale
under state securities laws to the extent deemed advisable by the Adviser.
4.2. Unless other arrangements are made, the Fund shall provide the
Company with: (i) a copy, in PDF and hard copy in final form no later than 15
calendar days before they must be mailed: Reports- February 13th and August
14th, Prospectuses-April 15th or otherwise suitable for printing or duplication,
of each Fund Prospectus and any supplement thereto and each Fund Statement of
Additional Information and any supplement thereto; and (ii) copies of the Fund's
proxy materials, reports to shareholders, and other communications to
shareholders in such quantity as the Company shall reasonably require for
distributing to Contract Owners.
7
4.3. The Company shall amend the Contracts' Registration Statement (if
any) and the Account's 1940 Act Registration Statement (if any) from time to
time as required in order to effect the continuous offering of the Contracts or
as may otherwise be required by applicable law. The Company shall file,
register, qualify and obtain approval of the Contracts for sale to the extent
required by applicable insurance and securities laws of the various states.
4.4. The Company shall inform the Fund of any investment restrictions
imposed by state insurance law that may become applicable to the Fund from time
to time as a result of the Account's investment therein (including, but not
limited to, restrictions with respect to fees and expenses and investment
policies), other than those set forth on Schedule 4 to this Agreement. Upon
receipt of such information from the Company, the Fund shall determine whether
it is in the best interests of shareholders to comply with any such
restrictions. If the Fund determines that it is not in the best interests of
shareholders (it being understood that "shareholders" for this purpose shall
mean Product Owners), the Fund shall so inform the Company, and the Fund and the
Company shall discuss alternative accommodations in the circumstances. If the
Fund determines that it is in the best interests of shareholders to comply with
such restrictions, the Fund and the Company shall amend Schedule 4 to this
Agreement to reflect such restrictions.
4.5. The Company shall provide Contracts, Contracts and Fund
Prospectuses, Contracts and Fund Statements of Additional Information, reports,
solicitations for voting instructions including any related Fund proxy
solicitation materials, and all amendments or supplements to any of the
foregoing, to Contract Owners and prospective Contract Owners, all in accordance
with the federal and any applicable state securities laws.
4.6. All expenses incident to each party's performance under this
Agreement (including expenses expressly assumed by such party pursuant to this
Agreement) shall be paid by such party to the extent permitted by law.
(a) Expenses assumed by the Fund include, but are not limited to,
the costs of: (i) registration and qualification of the Fund shares under
the federal securities laws; (ii) preparation and filing with the SEC of
the Fund Prospectus, Fund Registration Statement, Fund proxy materials and
shareholder reports, and preparation of a PDF copy thereof; (iii)
preparation of all statements and notices required for the Fund by any
federal or state securities law; (iv) printing and mailing to Contract
Owners of all proxy materials, prospectuses (including supplements) and
reports required to be provided by the Fund to its shareholders; (v) all
taxes on the issuance or transfer of Fund shares; and (vi) any expenses
permitted to be paid or assumed by the Fund pursuant to a plan, if any,
under Rule 12b-1 under the 1940 Act. The Fund otherwise shall pay no fee or
other compensation to the Company under this Agreement, unless the parties
otherwise agree, except that if the Fund or any Series adopts and
implements a plan pursuant to Rule 12b-1 under the 1940 Act to finance
distribution expenses, then payments may be made to the Company in
accordance with such plan. The Fund currently does not intend to make any
payments to finance distribution expenses pursuant to Rule 12b-1 under the
1940 Act or
8
in contravention of such rule, although it may make payments pursuant to
Rule 12b-1 in the future. To the extent that it decides to finance
distribution expenses pursuant to Rule 12b-1, the Fund undertakes to have a
Board of Directors, a majority of whom are not interested persons of the
Fund, formulate and approve any plan under Rule 12b-1 to finance
distribution expenses.
(b) Expenses assumed by the Company include, but are not limited
to, the costs of: (i) registration and qualification of the Contracts under
the federal and any applicable state securities laws; (ii) preparation and
filing with the SEC of the Contracts Prospectus and Contracts Registration
Statement; and (iii) preparation and dissemination of all statements and
notices to Contract Owners required by any federal or state insurance law
other than those paid for by the Fund.
4.7. Any piece of advertising or sales literature or other promotional
material in which the Fund is named and which will be used by the Company shall
be furnished by the Company to the Fund not less than 10 days prior to its use.
No such material shall be used if the Fund or its designee objects to such use
within 10 days after receipt of such material, provided that it may be used
earlier than the end of such 10 day period if the Fund or its designee consents
in writing to its use. The Fund may delegate its rights and responsibilities
under this provision to the Adviser.
4.8. Any piece of advertising or sales literature or other promotional
material in which the Company or the Account is named and which will be used by
the Fund or the Adviser shall be furnished by the Fund or the Adviser, as
applicable, to the Company not less than 10 days prior to its use. No such
material shall be used if the Company or its designee objects to such use within
10 days after receipt of such material, provided that it may be used earlier
than the end of such 10 day period if the Company or its designee consents in
writing to its use.
4.9. The Company shall not give any information or make any
representations or statements on behalf of the Fund or concerning the Fund to
the public (including current and prospective Contract owners) in connection
with the sale of the Contracts other than the information or representations
contained in the Fund Registration Statement or Fund Prospectus (as such
Registration Statement or Prospectus may be amended or supplemented from time to
time) or in reports or proxy statements for the Fund, or in sales literature or
other promotional material approved in accordance with Section 4.7 of this
Agreement, except with the prior written consent of the Fund.
4.10. The Fund and the Adviser shall not give any information or make
any representations on behalf of the Company or concerning the Company, the
Account or the Contracts other than the information or representations contained
in the Contracts' Registration Statement or Contracts Prospectus (as such
Registration Statement or Prospectus may be amended or supplemented from time to
time) or approved in writing by the Company for distribution to Contract Owners,
or in sales literature or other promotional material approved in accordance with
Section 4.8 of this Agreement except with the prior written consent of the
Company.
9
4.11. The Fund and the Company shall provide to the other upon request
at least one complete copy of all Registration Statements, Prospectuses,
Statements of Additional Information, periodic and other shareholder or Contract
Owner reports, proxy statements, solicitations of voting instructions, sales
literature and other promotional materials, applications for exemptions,
requests for no-action letters, and all amendments or supplements to any of the
above, that relate to the Fund, the Contracts or the Account, as the case may
be, promptly after the filing by or on behalf of such party of such document
with the SEC or other regulatory authorities.
4.12. Each party shall provide to the other upon request copies of
draft versions of any Registration Statements, Prospectuses, Statements of
Additional Information, periodic and other shareholder or Contract Owner
reports, proxy statements, solicitations for voting instructions, sales
literature and other promotional materials, applications for exemptions,
requests for no-action letters, and all amendments or supplements to any of the
above, to the extent that the other party reasonably needs such information for
purposes of preparing a report or other filing to be filed with or submitted to
a regulatory agency. If a party reasonably requests any such information before
it has been filed, the other party will provide the requested information if
then available and in the version then available at the time of such request.
4.13. Each party hereto shall cooperate with the other party and all
appropriate governmental authorities (including without limitation the SEC, the
NASD and state insurance regulators) and shall permit each other and such
authorities reasonable access to its books and records in connection with any
investigation or inquiry relating to this Agreement or the transactions
contemplated hereby. However, such access shall not extend to attorney-client
privileged information.
4.14. The Company reserves the right to modify any of the Contracts in
any respect whatsoever. The Company reserves the right in its sole discretion to
suspend the sale of any of the Contracts, in whole or in part, or to accept or
reject any application for the sale of a Contract. The Company agrees to notify
the Fund and the Adviser promptly upon the occurrence of any event the Company
believes might necessitate a material MODIFICATION OR SUSPENSION.
4.15. For purposes of this Article IV, the phrase "sales literature or
other promotional material" includes, but is not limited to, any material
constituting sales literature or advertising under the NASD rules, the 1940 Act
or the 1933 Act.
10
ARTICLE V. VOTING OF FUND SHARES
5.1. With respect to any matter put to vote by the holders of Fund
shares or Series shares ("Voting Shares"), to the extent required by law
(including the Exemptive Order referred to in Section 7.1 below) the Company
shall:
(a) solicit voting instructions from Contract Owners to which
Voting Shares are attributable;
(b) vote Voting Shares of each Series attributable to Contract
Owners in accordance with instructions or proxies timely received from such
Contract Owners;
(c) vote Voting Shares of each Series attributable to Contract
Owners for which no instructions have been received in the same proportion
as Voting Shares of such Series for which instructions have been timely
received; and
(d) vote Voting Shares of each Series held by the Company on its
own behalf or on behalf of the Account that are not attributable to
Contract Owners in the same proportion as Voting Shares of such Series for
which instructions have been timely received;
provided, however, that if the SEC changes its interpretations of voting
privileges for variable contracts the Company may vote such shares in its own
right. The Company shall be responsible for assuring that voting privileges for
the Account are calculated in a manner consistent with the provisions set forth
above.
5.2. The Fund will comply with all provisions of the 1940 Act
requiring voting by shareholders, and in particular the Fund will either provide
for annual meetings or comply with Section 16(c) of the 1940 Act (although the
Fund is not one of the trusts described in Section 16(c) of that Act) as well as
with Sections 16(a) and, if and when applicable, 16(b). Further, the Fund will
act in accordance with the Securities and Exchange Commission's interpretation
of the requirements of Section 16(a) with respect to periodic elections of
trustees and with whatever rules the Commission may promulgate with respect
thereto.
ARTICLE VI. COMPLIANCE WITH CODE
6.1. The Fund shall comply with Section 817(h) of the Code, and all
regulations issued thereunder and shall notify the Company immediately upon
having a reasonable basis for believing that it has ceased to so qualify or that
it might not so qualify in the future.
6.2. The Fund shall maintain its qualification as a regulated
investment company (under Subchapter M of the Code or any successor or similar
provision), and shall notify the Company immediately upon having a reasonable
basis for believing that it has ceased to so qualify or that it might not so
qualify in the future.
11
6.3. The Company shall maintain the treatment of the Contracts as
annuity contracts or life insurance policies, whichever is appropriate, under
applicable provisions of the Code and shall notify the Fund and the Adviser
immediately upon having a reasonable basis for believing that the Contracts have
ceased to be so treated or that they might not be so treated in the future.
ARTICLE VII. POTENTIAL CONFLICTS
7.1. The parties to this Agreement acknowledge that the Fund has
obtained (or will obtain) an order of exemption from the SEC (the "Exemptive
Order," File No. 812-9674) granting relief from various provisions of the 1940
Act and the rules thereunder to the extent necessary to permit Fund shares to be
sold to and held by variable annuity and variable life insurance separate
accounts of both affiliated and unaffiliated Participating Insurance Companies
and other Qualified Persons (as defined in Section 2.8). The Fund hereby
notifies the Company that Contracts Prospectus disclosure regarding potential
risks of such mixed and shared funding may be appropriate.
7.2. The Fund Board shall monitor the existence of any material
irreconcilable conflict between the interests of Product Owners. The Fund Board
shall promptly inform the Company if it determines that a material
irreconcilable conflict exists and the implications thereof.
7.3. (a) The Company shall report any potential or existing conflicts
promptly to the Fund Board, and in particular whenever Contract Owner
voting instructions are disregarded, and recognizes that it shall be
responsible for assisting the Fund Board in carrying out its
responsibilities in connection with the Exemptive Order. The Company agrees
to carry out such responsibilities with a view only to the interests of
Contract Owners.
(b) The Company shall at least annually submit to the Fund Board
such reports, materials or data as the Fund Board may reasonably request so
that the Fund Board and the Fund may fully carry out the obligations
imposed upon them by the conditions of the Exemptive Order, and such
reports, material and data shall be submitted more frequently if deemed
appropriate by the Fund Board.
7.4. If a majority of the Fund Board, or a majority of its directors
who are not "interested persons" as defined in the 1940 Act ("Disinterested
Directors"), determines that a material irreconcilable conflict exists with
regard to Contract Owner investments in the Fund, the Fund Board shall give
prompt notice to all Participating Insurance Companies. If the Fund Board
determines that the Company is responsible in full or in part for causing or
creating said conflict, the Company (and other responsible Participating
Insurance Companies) shall at no cost and expense to the Fund, and to the extent
reasonably practicable (as determined by a majority of
12
the Disinterested Directors), take such action as is necessary to remedy or
eliminate the irreconcilable material conflict. Such necessary action may
include, but shall not be limited to:
(a) Withdrawing the assets allocable to the Account from the Fund
or any portfolio thereof and reinvesting such assets in a different
investment medium, or submitting the question of whether such segregation
should be implemented to a vote of all affected Contract Owners and, as
appropriate, segregating the assets of any appropriate group (I.E., annuity
Contract Owners, life insurance Contract Owners, or other Product Owners)
that votes in favor of such segregation or offering to the affected
Contract Owners the option of making such a change; and
(b) Establishing a new registered management investment company.
7.5. If a material irreconcilable conflict arises as a result of a
decision by the Company to disregard Contract Owner voting instructions and said
decision represents a minority position or would preclude a majority vote by all
Contract Owners having an interest in the Fund, the Company may be required, at
the Fund Board's election, to withdraw the Account's investment in the Fund and
terminate this Agreement with respect to such Account; provided, however, that
such withdrawal and termination shall be limited to the extent required by the
foregoing material irreconcilable conflict as determined by a majority of the
Disinterested Directors. Any such withdrawal and termination must take place
within six (6) months or whenever a substitution order has been approved by the
SEC, after the Fund gives written notice that this provision is being
implemented, and until the end of that six month period or whenever a
substitution order has been approved by the SEC, the Adviser and fund shall
continue to accept and implement orders by the Company for the purchase (and
redemption) of shares of the Fund (subject to Section 2.1 above). No charge or
penalty will be imposed as a result of such withdrawal.
7.6. If a material irreconcilable conflict arises because a particular
state insurance regulator's decision applicable to the Company conflicts with
the majority of other state regulators, then the Company will withdraw the
affected Account's investment in the Fund and terminate this Agreement with
respect to such Account within six months or whenever a substitution order has
been approved by the SEC after the Board informs the Company in writing that it
has determined that such decision has created an irreconcilable material
conflict; provided, however, that such withdrawal and termination shall be
limited to the extent required by the foregoing material irreconcilable conflict
as determined by a majority of the Disinterested Directors. Until the end of the
foregoing six month period or whenever a substitution order has been approved by
the SEC, the Adviser and Fund shall continue to accept and implement orders by
the Company for the purchase (and redemption) of shares of the Fund (subject to
Section 2.1 above).
7.7. For purposes of this Article, a majority of the Disinterested
Directors shall determine whether or not any proposed action adequately remedies
any irreconcilable material conflict, but in no event shall the Fund be required
to bear the expense of establishing a new funding medium for any Contract. The
Company shall not be required by this Article to
13
establish a new funding medium for any Contract. In the event that the Board
determines that any proposed action does not adequately remedy any
irreconcilable material conflict, then the Company will withdraw the Account's
investment in the Fund and terminate this Agreement within six (6) months or
whenever a substitution order has been approved by the SEC after the Board
informs the Company in writing of the foregoing determination, provided,
however, that such withdrawal and termination shall be limited to the extent
required by any such material irreconcilable conflict as determined by a
majority of the Disinterested Directors.
7.8. If and to the extent that Rule 6e-2 and Rule 6e-3(T) are amended,
or Rule 6e-3 is adopted, to provide exemptive relief from any provisions of the
1940 Act or the rules promulgated thereunder with respect to mixed and shared
funding on terms and conditions materially different from those contained in the
Exemptive Order, then (a) the Fund and/or the Company, as appropriate, shall
take such steps as may be necessary to comply with Rules 6e-2 and 6e-3(T), as
amended, or Rule 6e-3, as adopted, as applicable, to the extent such rules are
applicable, and (b) Sections 7.2 through 7.7 of this Agreement shall continue in
effect only to the extent that terms and conditions substantially identical to
such Sections are contained in such Rule(s) as so amended or adopted.
ARTICLE VIII. INDEMNIFICATION
8.1. INDEMNIFICATION BY THE COMPANY. The Company shall indemnify and
hold harmless the Fund, the Adviser and each person who controls the Fund or the
Adviser within the meaning of such terms under the 1933 Act (but not any
Participating Insurance Companies or Qualified Plans) and any officer, trustee,
director, employee or agent of the foregoing, against any and all losses,
claims, damages or liabilities, joint or several (including any investigative,
legal and other expenses reasonably incurred in connection with, and any amounts
paid with the written consent of the Company in settlement of, any action, suit
or proceeding or any claim asserted), to which they or any of them may become
subject under any statute or regulation, at common law or otherwise, insofar as
such losses, claims, damages or liabilities are related to the sale or
acquisition of the Fund's shares or the Contracts and:
(a) arise out of or are based upon any untrue statement or
alleged untrue statement of any material fact contained in the Contracts
Registration Statement, Contracts Prospectus, sales literature or other
promotional material for the Contracts or the Contracts themselves (or any
amendment or supplement to any of the foregoing), or the omission or the
alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements therein not misleading in light
of the circumstances in which they were made; provided that this obligation
to indemnify shall not apply if such statement or omission or such alleged
statement or alleged omission was made in reliance upon and in conformity
with information furnished in writing to the Company by or on behalf of the
Fund or Adviser for use in the Contracts Registration Statement, Contracts
Prospectus or in the Contracts or sales literature or promotional material
for the Contracts (or any amendment or supplement to any of the foregoing)
or otherwise for use in connection with the sale of the Contracts or Fund
shares; or
14
(b) arise out of any untrue statement or alleged untrue statement
of a material fact contained in the Fund Registration Statement, Fund
Prospectus or sales literature or other promotional material of the Fund
(or any amendment or supplement to any of the foregoing), or the omission
or alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements therein not misleading in light
of the circumstances in which they were made, if such statement or omission
was made in reliance upon and in conformity with information furnished in
writing to the Fund or the Adviser by or on behalf of the Company; or
(c) arise out of or are based upon any wrongful conduct of the
Company or persons under its control (or subject to its authorization) with
respect to the sale or distribution of the Contracts or Fund shares; or
(d) arise as a result of any failure by the Company to provide
the services and furnish the materials or to make any payments as required
under this Agreement; or
(e) arise out of any material breach by the Company of this
Agreement.
This indemnification will be in addition to any liability that the Company may
otherwise have; provided, however, that no party shall be entitled to
indemnification if such loss, claim, damage or liability is due to the wilful
misfeasance, bad faith, gross negligence or reckless disregard of duty by the
party seeking indemnification.
8.2. INDEMNIFICATION BY THE FUND. The Fund shall indemnify and hold
harmless the Company and each person who controls the Company within the meaning
of such terms under the 1933 Act and any officer, director, employee or agent of
the foregoing, against any and all losses, claims, damages or liabilities, joint
or several (including any investigative, legal and other expenses reasonably
incurred in connection with, and any amounts paid with the written consent of
the Fund in settlement of, any action, suit or proceeding or any claim
asserted), to which they or any of them may become subject under any statute or
regulation, at common law or otherwise, insofar as such losses, claims, damages
or liabilities are related to the sale or acquisition of the Fund's shares or
the Contracts and:
(a) arise out of or are based upon any untrue statement or
alleged untrue statement of any material fact contained in the Fund
Registration Statement, Fund Prospectus or sales literature or other
promotional material of the Fund (or any amendment or supplement to any of
the foregoing), or the omission or the alleged omission to state therein a
material fact required to be stated therein or necessary to make the
statements therein not misleading in light of the circumstances in which
they were made; provided that this obligation to indemnify shall not apply
if such statement or omission or alleged statement or alleged omission was
made in reliance upon and in conformity with information furnished in
writing to the Fund by or on behalf of the Company for use in the Fund
Registration Statement, Fund Prospectus or sales literature
15
or promotional material for the Fund (or any amendment or supplement to any
of the foregoing); or
(b) arise out of any untrue statement or alleged untrue statement
of a material fact contained in the Contracts Registration Statement,
Contracts Prospectus or sales literature or other promotional material for
the Contracts (or any amendment or supplement to any of the foregoing), or
the omission or alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements therein not
misleading in light of the circumstances in which they were made, if such
statement or omission was made in reliance upon information furnished in
writing by or on behalf of the Fund to the Company; or
(c) arise out of or are based upon wrongful conduct of the Fund
or persons under its control (or subject to its authorization) with respect
to the sale of Fund shares; or
(d) arise as a result of any failure by the Fund to provide the
services and furnish the materials required under the terms of this
Agreement; or
(e) arise out of any material breach by the Fund of this
Agreement (including any breach of Article VI of this Agreement).
This indemnification will be in addition to any liability that the Fund may
otherwise have; provided, however, that no party shall be entitled to
indemnification if such loss, claim, damage or liability is due to the wilful
misfeasance, bad faith, gross negligence or reckless disregard of duty by the
party seeking indemnification.
8.3. INDEMNIFICATION BY THE ADVISER. The Adviser shall indemnify and
hold harmless the Company and each person who controls the Company within the
meaning of such term under the 1933 Act and any officer, director, employee or
agent of the foregoing, against any and all losses, claims, damages or
liabilities, joint or several (including any investigative, legal and other
expenses reasonably incurred in connection with, and any amounts paid with the
written consent of the Adviser in settlement of, any action, suit or proceeding
or any claim asserted), to which they or any of them may become subject under
any statute or regulation, at common law or otherwise, insofar as such losses,
claims, damages or liabilities are related to the sale or acquisition of the
Fund's shares or the Contract and:
(a) arise out of or are based upon any untrue statement or
alleged untrue statement of any material fact contained in the Fund
Registration Statement, Fund Prospectus or sales literature or other
promotional material of the Fund (or any amendment or supplement to any of
the foregoing), or the omission or the alleged omission to state therein a
material fact required to be stated therein or necessary to make the
statements therein not misleading in light of the circumstances in which
they were made; provided that this obligation to indemnify shall not apply
if such statement or omission or alleged statement or alleged omission was
made in reliance upon and in
16
conformity with information furnished in writing by or on behalf of the
Company to the Fund or the Adviser for use in the Fund Registration
Statement, Fund Prospectus or sales literature or promotional material for
the Fund (or any amendment or supplement to any of the foregoing); or
(b) arise out of any untrue statement or alleged untrue statement
of a material fact contained in the Contracts Registration Statement,
Contracts Prospectus or sales literature or other promotional material for
the Contracts (or any amendment or supplement to any of the foregoing), or
the omission or alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements therein not
misleading in light of the circumstances in which they were made, if such
statement or omission was made in reliance upon information furnished in
writing by or on behalf of the Adviser to the Company; or
(c) arise out of or are based upon wrongful conduct of the Fund
or the Adviser with respect to the sale of Fund shares; or
(d) arise as a result of any failure by the Fund or the Adviser
to provide the services and furnish the materials required under the terms
of this Agreement; or
(e) arise out of any material breach by the Fund or the Adviser
of this Agreement (including any breach of Article VI of this Agreement).
This indemnification will be in addition to any liability that the Adviser may
otherwise have; provided, however, that no party shall be entitled to
indemnification if such loss, claim, damage or liability is due to the wilful
misfeasance, bad faith, gross negligence or reckless disregard of duty by the
party seeking indemnification.
17
8.4. INDEMNIFICATION PROCEDURES. After receipt by a party entitled to
indemnification ("indemnified party") under this Article VIII of notice of the
commencement of any action, if a claim in respect thereof is to be made by the
indemnified party against any person obligated to provide indemnification under
this Article VIII ("indemnifying party"), such indemnified party will notify the
indemnifying party in writing of the commencement thereof as soon as practicable
thereafter, provided that the omission to so notify the indemnifying party will
not relieve it from any liability under this Article VIII, except to the extent
that the omission results in a failure of actual notice to the indemnifying
party and such indemnifying party is damaged solely as a result of the failure
to give such notice. The indemnifying party, upon the request of the indemnified
party, shall retain counsel reasonably satisfactory to the indemnified party to
represent the indemnified party and any others the indemnifying party may
designate in such proceeding and shall pay the fees and disbursements of such
counsel related to such proceeding. In any such proceeding, any indemnified
party shall have the right to retain its own counsel and to participate in the
defense of such proceeding, but the fees and expenses of such counsel shall be
at the expense of such indemnified party unless (i) the indemnifying party and
the indemnified party shall have mutually agreed to the retention of such
counsel or (ii) the named parties to any such proceeding (including any
impleaded parties) include both the indemnifying party and the indemnified party
and representation of both parties by the same counsel would be inappropriate
due to actual or potential differing interests between them. The indemnifying
party shall not be liable for any settlement of any proceeding effected without
its written consent but if settled with such consent or if there be a final
judgment against the indemnified party, the indemnifying party agrees to
indemnify the indemnified party from and against any loss or liability by reason
of such settlement or judgment.
A successor by law of the parties to this Agreement shall be entitled
to the benefits of the indemnification contained in this Article VIII. The
indemnification provisions contained in this Article VIII shall survive any
termination of this Agreement.
ARTICLE IX. APPLICABLE LAW
9.1. This Agreement shall be construed and the provisions hereof
interpreted under and in accordance with the laws of the State of Maryland,
without giving effect to the principles of conflicts of law.
9.2. This Agreement shall be subject to the provisions of the 1933
Act, 1940 Act and Securities Exchange Act of 1934, as amended, and the rules and
regulations and rulings thereunder, including such exemptions from those
statutes, rules and regulations as the SEC may grant, and the terms hereof shall
be limited, interpreted and construed in accordance therewith.
18
ARTICLE X. TERMINATION
10.1 This Agreement shall not terminate until the Fund is dissolved,
liquidated, or merged into another entity, or, as to any Series of the Fund, the
Account no longer invests in that Series. However, this Agreement may be
terminated (a) by either party at any time, without the payment of any penalty,
on not less than 90 days' written notice to the other party, or (b) certain
obligations of, or restrictions on, the parties to this Agreement may terminate
as provided in Sections 10.2 and 10.3, and the Company may be required to redeem
shares pursuant to Section 10.4 or in the circumstances contemplated by Article
VII.
10.2. TERMINATION OF THE FUND'S OBLIGATION TO SELL. The obligation of
the Fund to sell shares to the Company pursuant to Article II of this Agreement
shall terminate at the option of the Fund upon notice to the Company as provided
below:
(a) the Fund Board has terminated the offering of Fund shares or
Series shares pursuant to Section 2.1 of this Agreement; or
(b) upon institution of formal proceedings against the Company by
the NASD, the SEC, the insurance commission of any state or any other
regulatory body regarding the Company's duties under this Agreement or
related to the sale of the Contracts, the operation of the Account, the
administration of the Contracts or the purchase of Fund shares, or an
expected or anticipated ruling, judgment or outcome which would, in the
Fund's reasonable judgment, materially impair the Company's ability to meet
and perform the Company's obligations and duties hereunder; or
(c) in the event any of the Contracts are not registered, issued
or sold in accordance with applicable federal and/or state law; or
(d) if the Fund or the Adviser, respectively, shall determine, in
their sole judgment exercised in good faith, that either (1) the Company
shall have suffered a material adverse change in its business or financial
condition since the date of this Agreement or (2) the Company shall have
been the subject of material adverse publicity which is likely to have a
material adverse impact upon the business and operations of either the Fund
or the Adviser; or
(e) upon the Company's assignment of this Agreement (including,
without limitation, any transfer of any Contract or the Account to another
insurance company pursuant to an assumption reinsurance agreement) unless
the Fund consents thereto; or
(f) upon termination pursuant to Section 10.1 or notice from the
Company pursuant to Section 10.3.
Termination of the Fund's obligation shall take effect immediately upon the
giving of such notice upon the occurrence of an event described in clauses (b)
or (c) above, and 10 (ten) days after the
19
giving of such notice in all other cases. In exercising its option to terminate
its obligation to sell shares to the Company, the Fund will continue to make
Fund shares available to the extent necessary to permit owners of Contracts in
effect on the effective date of such termination (hereinafter referred to as
"Existing Contracts") to reallocate investments in the Fund, redeem investments
in the Fund and/or invest in the Fund upon the making of additional purchase
payments under the Existing Contracts, unless the Existing Contracts are the
basis for the termination. In that case, the Fund may nonetheless elect to
continue to make Fund shares available for Existing Contracts and if it so
elects, shall promptly notify the Company whether the Fund is electing to make
Fund shares available after termination.
10.3. AS TO THE COMPANY. The restrictions on the Company under Section
2.7(a) of this Agreement shall terminate at the option of the Company upon 10
days' notice to the Fund:
(a) if shares of any Series are not reasonably available to meet
the requirements of the Contracts as determined by the Company, and the
Fund, after receiving written notice from the Company of such
non-availability, fails to make available a sufficient number of Fund
shares to meet the requirements of the Contracts within 10 days after
receipt thereof; or
(b) upon institution of formal proceedings against the Fund by
the NASD, the SEC or any state securities or insurance commission or any
other regulatory body; or
(c) if the Fund ceases to qualify as a regulated investment
company under Subchapter M of the Code, or under any successor or similar
provision, or if the Company reasonably believes the Fund may fail to so
qualify, and the Fund, upon written request, fails to provide reasonable
assurance that it will take action to cure or correct such failure; or
(d) if the Fund fails to meet the diversification requirements
specified in Section 817(h) of the Code and any regulations thereunder, and
the Fund, upon written request, fails to provide reasonable assurance that
it will take action to cure or correct such failure; or
(e) if the Fund informs the Company pursuant to Section 4.4 that
the Fund will not comply with investment restrictions as requested by the
Company, and the Fund and the Company are unable to agree upon any
reasonable alternative accommodations; or
(f) upon receipt by the Company of any necessary regulatory
approvals and the vote of the Contract Owners having an interest in the
Account (or any subaccount) to substitute the shares of another investment
company for the corresponding Portfolio shares of the Fund in accordance
with the terms of the Contracts for which those Portfolio shares had been
selected to serve as the underlying investment media. The Company will give
30 days' prior written notice to the Fund of the date of any proposed vote
or other action taken to replace the Fund's shares; or
20
(g) upon a material breach of any provision of this Agreement by
either the Fund or the Adviser; or
(h) if the Company determines in its sole judgment exercised in
good faith, that either the Fund or the Adviser has suffered a material
adverse change in its business, operations, or financial conditions since
the date of this Agreement or is the subject of material adverse publicity
which is likely to have a material adverse impact upon the business and
operations of the Company.
10.4. COMPANY REQUIRED TO REDEEM. The parties understand and
acknowledge that it is essential for compliance with Section
817(h) of the Code that the Contracts qualify as annuity
contracts or life insurance policies, as applicable, under the
Code. Accordingly, if any of the Contracts cease to qualify as
annuity contracts or life insurance policies, as applicable,
under the Code, or if the Fund reasonably believes that any such
Contracts may fail to so qualify and the Company fails to provide
reasonable assurance that it will take action to cure or correct
such failure, the Fund shall have the right to require the
Company to redeem Shares attributable to such Contracts upon ten
(10) days written notice to the Company and the Company shall so
redeem such Shares in order to ensure that the Fund complies with
the provisions of Section 817(h) of the Code applicable to
ownership of Fund Shares. Notice to the Company shall specify the
period of time the Company has to redeem the Shares or to make
other arrangements satisfactory to the Fund and its counsel, such
period of time to be determined with reference to the
requirements of Section 817(h) of the Code. In addition, the
Company may be required to redeem Shares pursuant to action taken
or request made by the Fund Board in accordance with an order of
the SEC as described in Article VII, or other SEC rule,
regulation or order that may be adopted after the date hereof.
The Company agrees to redeem Shares in such circumstances and to
comply with applicable terms and provisions.
21
ARTICLE XI. APPLICABILITY TO NEW ACCOUNTS AND NEW CONTRACTS
The parties to this Agreement may amend the schedules to this
Agreement from time to time to reflect, as appropriate, changes in or relating
to the Contracts, or Series or funding vehicles thereof, additions of new
classes of Contracts to be issued by the Company and separate accounts therefor
investing in the Fund. The provisions of this Agreement shall be equally
applicable to each such class of Contracts, Series and Accounts, effective as of
the date of amendment of such Schedule, unless the context otherwise requires.
ARTICLE XII. NOTICE, REQUEST OR CONSENT
Any notice, request or consent to be provided pursuant to this
Agreement is to be made in writing and shall be given:
If to the Fund prior to June 1, 2003:
M Fund, Inc.
River Park Center
000 X.X. Xxxxxxx Xxxxxx
Xxxxxxxx, Xxxxxx 00000
Attn: President
If to the Fund after June 1, 2003:
M Fund, Inc.
M Financial Plaza
0000 XX Xxxxx Xxxxxx
Xxxxxxxx, XX 00000
Attn: President
If to the Adviser prior to June 1, 2003:
M Financial Investment Advisers, Inc.
River Park Center
000 X.X. Xxxxxxx Xxxxxx
Xxxxxxxx, Xxxxxx 00000
Attn: President
22
If to the Adviser after June 1, 2003:
M Financial Investment Advisers, Inc.
M Financial Plaza
0000 XX Xxxxx Xxxxxx
Xxxxxxxx, XX 00000
Attn: President
If to the Company:
Lincoln Life & Annuity Company of New York
000 Xxxxxxx Xxxxxx, Xxxxx 0000
Xxxxxxxx, XX 00000
Attn: President
or at such other address as such party may from time to time specify in writing
to the other party. Each such notice, request or consent to a party shall be
sent by registered or certified United States mail with return receipt
requested, by overnight delivery with a nationally recognized courier or by
electronically transmitted facsimile, and shall be effective upon receipt or
three days after mailing.
ARTICLE XIII. MISCELLANEOUS
13.1. The captions in this Agreement are included for convenience of
reference only and in no way define or delineate any of the provisions hereof or
otherwise affect their construction or effect.
13.2. This Agreement may be executed simultaneously in two or more
counterparts, each of which together shall constitute one and the same
instrument.
13.3. If any provision of this Agreement shall be held or made invalid
by a court decision, statute, rule or otherwise, the remainder of this Agreement
shall not be affected thereby.
13.4. Subject to the requirement of legal process and regulatory
authority, each party hereto shall treat as if confidential the names and
addresses of the owners of the Contracts and all information reasonably
identified as confidential in writing by any other party hereto and, except as
permitted by this Agreement shall not disclose, disseminate, or utilize such
names and addresses and other confidential information until such time as it may
come into the public domain without the express written consent of the affected
party.
13.5. The rights, remedies, and obligations contained in this
Agreement are cumulative and are in addition to any and all rights, remedies,
and obligations, at law or in equity, which the parties hereto are entitled to
under state and federal laws.
23
IN WITNESS WHEREOF, each of the parties hereto has caused this
Agreement to be executed in its name and behalf by its duly authorized officer
on the date specified below.
LINCOLN LIFE & ANNUITY COMPANY OF NEW YORK
(Company)
Date: 5/1/03 By: /s/ Rise X. X. Xxxxxx
Name: Rise X. X. Xxxxxx
Title: 2nd Vice President
M FUND, INC.
(Fund)
Date: 5/1/03 By: /s/ Xxxxxx X. Xxxxx
Name: Xxxxxx X. Xxxxx
Title: President
M FINANCIAL INVESTMENT ADVISERS, INC.
(Adviser)
Date: 5/1/03 By: /s/ Xxxxxx X. Xxxxx
Name: Xxxxxx X. Xxxxx
Title: President
24
SCHEDULE 1
Accounts of the Company
Investing in the Fund
Effective as of the date the Agreement was executed, the following separate
accounts of the Company are subject to the Agreement:
DATE ESTABLISHED BY SEC 1940 ACT
NAME OF ACCOUNT AND BOARD OF DIRECTORS OF THE REGISTRATION NUMBER TYPE OF PRODUCT
SUBACCOUNTS COMPANY (IF APPLICABLE) SUPPORTED BY ACCOUNT
----------------------------- --------------------------- ------------------------- --------------------
Lincoln Life Flexible November 24, 1997 811-08559 Variable Life
Premium Variable Life
Account M
LLANY Separate January 29, 1998 811-08651 Variable Life
Account R for Flexible
Premium Variable Life
Insurance
SCHEDULE 2
Classes of Contracts
Supported by Separate Accounts
Listed on Schedule 1
Effective as of the date the Agreement was executed, the following classes of
Contracts are subject to the Agreement:
SEC 1933 ACT
REGISTRATION NUMBER NAME OF SUPPORTING
POLICY MARKETING NAME (IF APPLICABLE) ACCOUNT ANNUITY OR LIFE
------------------------ ---------------------- --------------------- ---------------
VULCV-III 333-084684 LLANY Account M Life
VULDB-II 333-084688 LLANY Account M Life
SVUL-III 333-090508 LLANY Account M Life
SCHEDULE 3
Fund Series and Other Funding
Vehicles Available Under
Each Class of Contracts
Effective as of the date the Agreement was executed, the following Fund Series
are available under the Contracts:
M Fund, Inc. Fund Series:
Xxxxxxx International Equity Fund
Frontier Capital Appreciation Fund
Xxxxxx Core Growth Fund
Business Opportunity Value Fund
SCHEDULE 4
Investment Restrictions
Applicable to the Fund
Effective as of the date the Agreement was executed, the following investment
restrictions are applicable to the Fund:
The California Department of Insurance has established the following Guidelines
for an underlying portfolio of a Separate Account:
Borrowing. Borrowing limits for any variable contract separate account portfolio
are (1) 10% of net asset value when borrowing for any general purpose; and (2)
25% of net asset value when borrowing as a temporary measure to facilitate
redemptions. Net asset value of a portfolio is the market value of all
investments or assets owned less outstanding liabilities of the portfolio at the
time that any new or additional borrowing is undertaken.
Foreign Investments- Diversification.
1. A portfolio will be invested in a minimum of five different foreign
countries at all times. However, this minimum is reduced to four when
foreign investments comprise less than 80% of the portfolio's net
asset value; to three when less than 60% of that value; to two when
less than 40%; and to one when less than 20%.
2. Except as set forth in item 3 and 4 below, a Portfolio will have no
more than 20% of its net asset value invested in securities of issuers
located in any one country.
3. A Portfolio may have an additional 15% of its net asset value invested
in scurities of issuers located in any one of the following countries:
Australia, Canada, France, Japan, the United Kingdom, or Germany.
4. A Portfolio's investments in the United States issuers are not subject
to the foreign country diversification guidelines.
Effective as of July 1, 2003, the following separate accounts of the Company are
hereby added to this Schedule 1 and made subject to the Agreement:
DATE ESTABLISHED BY SEC 1940 ACT
NAME OF ACCOUNT AND BOARD OF DIRECTORS OF THE REGISTRATION NUMBER TYPE OF PRODUCT
SUBACCOUNTS COMPANY (IF APPLICABLE) SUPPORTED BY ACCOUNT
----------------------------- --------------------------- ------------------------- --------------------
LLANY Separate March 2, 1999 811-09257 Variable Life
Account S for Flexible
Premium Variable Life
Insurance
811-
811-
IN WITNESS WHEREOF, the Fund, the Adviser, and the Company hereby amend this
Schedule 1 in accordance with Article XI of the Agreement.
M FUND, INC. LINCOLN LIFE & ANNUITY COMPANY OF NEW
YORK
By: /s/ Xxxxxx X. Xxxxx By: /s/ Rise X. X. Xxxxxx
Name: Xxxxxx X. Xxxxx Name: Rise X. X. Xxxxxx
Title: President Title: Second Vice President
M FINANCIAL INVESTMENT ADVISERS, INC.
By: /s/ Xxxxxx X. Xxxxx
Name: Xxxxxx X. Xxxxx
Title: President
Effective as of July 1, 2003, the following classes of Contracts are hereby
added to this Schedule 2 and made subject to the Agreement:
SEC 1933 ACT
REGISTRATION NUMBER NAME OF SUPPORTING
POLICY MARKETING NAME (IF APPLICABLE) ACCOUNT ANNUITY OR LIFE
------------------------ ---------------------- ----------------------- ---------------
Lincoln Corporate 333-107461 LLANY Separate Life
Variable 4 Account S for Flexible
Premium Variable Life
Insurance
33-
33-
IN WITNESS WHEREOF, the Fund, the Adviser, and the Company hereby amend this
Schedule 2 in accordance with Article XI of the Agreement.
M FUND, INC. LINCOLN LIFE & ANNUITY COMPANY OF NEW
YORK
By: /s/ Xxxxxx X. Xxxxx By: /s/ Rise X. X. Xxxxxx
Name: Xxxxxx X. Xxxxx Name: Rise X. X. Xxxxxx
Title: President Title: Second Vice President
M FINANCIAL INVESTMENT ADVISERS, INC.
By: /s/ Xxxxxx X. Xxxxx
Name: Xxxxxx X. Xxxxx
Title: President
Effective as of May 1, 2004, the following separate accounts of the Company are
hereby added to this Schedule 1 and made subject to the Agreement:
DATE ESTABLISHED BY SEC 1940 ACT
NAME OF ACCOUNT AND BOARD OF DIRECTORS OF THE REGISTRATION NUMBER TYPE OF PRODUCT
SUBACCOUNTS COMPANY (IF APPLICABLE) SUPPORTED BY ACCOUNT
----------------------------- --------------------------- ------------------------- --------------------
Lincoln New York March 11, 1999 811-09763 Variable Annuities
Account N for Variable
Annuities
811-
811-
IN WITNESS WHEREOF, the Fund, the Adviser, and the Company hereby amend this
Schedule 1 in accordance with Article XI of the Agreement.
M FUND, INC. LINCOLN LIFE & ANNUITY COMPANY OF NEW
YORK
By: /s/ Xxx Xxxxx By: /s/ Rise X. X. Xxxxxx
Name: Xxx Xxxxx Name: Rise X. X. Xxxxxx
Title: President Title: Second Vice President
M FINANCIAL INVESTMENT ADVISERS, INC.
By: /s/ Xxx Xxxxx
Name: Xxx Xxxxx
Title: President
Effective as of May 1, 2004, the following classes of Contracts are hereby added
to this Schedule 2 and made subject to the Agreement:
SEC 1933 ACT
REGISTRATION NUMBER NAME OF SUPPORTING
POLICY MARKETING NAME (IF APPLICABLE) ACCOUNT ANNUITY OR LIFE
------------------------ ---------------------- ---------------------------- ---------------
Lincoln ChoicePlus 333-119531 Lincoln New York Annuity
Momentum Income(SM) Account N for Variable
Option Annuities
Lincoln VUL(DB) IV 333-118479 Lincoln Life & Annuity Life
Flexible Premium
Variable Life Account M
Lincoln VUL(CV) IV 333-118480 Lincoln Life & Annuity Life
Flexible Premium
Variable Life Account M
Lincoln Momentum 333-115839 Lincoln Life & Annuity Life
VUL(ONE) Flexible Premium
Variable Life Account M
Lincoln SVUL IV 333-115884 LLANY Separate Life
Account R for Flexible
Premium Variable Life
Insurance
IN WITNESS WHEREOF, the Fund, the Adviser, and the Company hereby amend this
Schedule 2 in accordance with Article XI of the Agreement.
M FUND, INC. LINCOLN LIFE & ANNUITY COMPANY OF NEW
YORK
By: /s/ Xxx Xxxxx By: /s/ Rise X. X. Xxxxxx
Name: Xxx Xxxxx Name: Rise X. X. Xxxxxx
Title: President Title: Second Vice President
M FINANCIAL INVESTMENT ADVISERS, INC.
By: /s/ Xxx Xxxxx
Name: Xxx Xxxxx
Title: President
Effective as of May 1, 2006, the following classes of Contracts are hereby added
to this Schedule 2 and made subject to the Agreement:
Policy Marketing Name SEC 1933 Act Name of Supporting Annuity or Life
Registration Number Account
(if applicable)
---------------------- --------------------- ---------------------- ---------------
Lincoln Momentum 333-125993 LLANY Separate Life
SVULONE Account R for Flexible
Premium Variable Life
Insurance
IN WITNESS WHEREOF, the Fund, the Adviser, and the Company hereby amend this
Schedule 2 in accordance with Article XI of the Agreement.
M FUND, INC. LINCOLN LIFE & ANNUITY COMPANY OF NEW YORK
By: /s/ Xxxxxx Xxxxxx By: /s/ Xxxxx X. Xxxxxxxxx
Name: Xxxxxx Xxxxxx Name: Xxxxx X. Xxxxxxxxx
Title: President Title: Second Vice President
M FINANCIAL INVESTMENT ADVISERS, INC.
By: /s/ Xxxxxx Xxxxxx
Name: Xxxxxx Xxxxxx
Title: President
Effective as of May 1, 2006, the following classes of Contracts are hereby
added to this Schedule 2 and made subject to the Agreement:
POLICY MARKETING NAME SEC 1933 ACT NAME OF SUPPORTING ANNUITY OR LIFE
REGISTRATION NUMBER ACCOUNT
(IF APPLICABLE)
--------------------- ------------------- ------------------ ---------------
Lincoln Momentum SVULONE 333-125993 LLANY Separate Life
Account R for Flexible
Premium Variable Life
Insurance
IN WITNESS WHEREOF, the Fund, the Adviser, and the Company hereby amend this
Schedule 2 in accordance with Article XI of the Agreement.
M FUND, INC. LINCOLN LIFE & ANNUITY COMPANY OF NEW YORK
By: /s/ Xxxxxx Xxxxxx By: /s/ Xxxxx X. Xxxxxxxxx
Name: Xxxxxx Xxxxxx Name:Xxxxx X. Xxxxxxxxx
Title: President Title: Second Vice President
M FINANCIAL INVESTMENT ADVISERS, INC.
By: /s/ Xxxxxx Xxxxxx
Name: Xxxxxx Xxxxxx
Title: President
AMENDMENT TO
PARTICIPATION AGREEMENT
This Amendment to the
Participation Agreement (the Agreement) dated May 1,
2003, by and among M Fund, Inc., M Financial Investment Advisers, Inc. and
Lincoln Life & Annuity Company of New York is effective, regardless of when
executed, upon the acceptance of certificates of merger by the states of New
York and New Jersey, as filed by Lincoln Life & Annuity Company of New York
and Jefferson Pilot LifeAmerica Life Insurance Company ("JPLA"), respectively.
WHEREAS, a merger of Lincoln Life & Annuity Company of New York and JPLA
is expected to occur on or about April 2, 2007;
WHEREAS, effective on or about Xxxxx 0, 0000, XXXX will change its state
of domicile from New Jersey to New York and will change its name to Lincoln
Life & Annuity Company of New York;
NOW, THEREFORE, for good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the parties agree to amend the
Agreement as follows:
ASSIGNMENT. The parties consent to an assignment of the responsibilities
and obligations of the former Lincoln Life & Annuity Company of New York
under this Agreement to the new Lincoln Life & Annuity Company of New York.
IN WITNESS WHEREOF, each of the parties has caused this Amendment to be
executed in its name and on behalf of its duly authorized officer listed
below.
M FUND, INC. LINCOLN LIFE & ANNUITY COMPANY OF
NEW YORK
By: /s/ Xxxxxx Xxxxxx By: /s/ Xxxxx X. Xxxxxxxxx
Name: Xxxxxx Xxxxxx Name: Xxxxx X. Xxxxxxxxx
Title: President Title: Second Vice President
M FINANCIAL INVESTMENT ADVISERS, INC.
By: /s/ Xxxxxx Xxxxxx
Name: Xxxxxx Xxxxxx
Title: President
AMENDMENT
TO
PARTICIPATION AGREEMENT
This AMENDMENT (this "AMENDMENT") is dated as of April 16, 2007 by and
among M FUND, INC., a corporation organized and existing under the laws of
the State of
Maryland (the "FUND"), M FINANCIAL ADVISERS, INC., a corporation
organized and existing under the laws of the State of Colorado (the
"ADVISER"), and THE LINCOLN LIFE & ANNUITY COMPANY OF NEW YORK, a life
insurance company organized and existing under the laws of the State of New
York (the "COMPANY").
WHEREAS, the Fund, the Adviser and the Company are parties to a
Participation Agreement entered into on May 1, 2003, as subsequently amended
(the "AGREEMENT");
WHEREAS, the parties wish to amend certain provisions of the Agreement as
set forth herein, and in particular the parties desire to amend the Agreement
to comply with SEC Rule 22c-2 promulgated under the Investment Company Act of
1940 (the "1940 ACT");
WHEREAS, the Company is an insurance company that has established certain
segregated asset accounts (each an "ACCOUNT") to fund the obligations of
certain variable universal life insurance policies and variable annuity
contracts ("CONTRACTS");
WHEREAS, to fund the obligations of the Contracts, the Accounts purchase
Shares pursuant to the Agreement;
WHEREAS, the Fund has requested that the Company agree to restrict or
prohibit trading by holders of Contracts ("CONTRACT OWNERS") when directed to
do so by the Fund, the Adviser or either of their designees; and
WHEREAS, capitalized terms used, but not defined, in this Amendment have
the meanings assigned to such terms in the Agreement.
NOW THEREFORE, in consideration of the mutual promises, representations,
and warranties made herein, covenants and agreements hereinafter contained,
and for other good and valuable consideration, the receipt and sufficiency of
which are acknowledged, the parties agree as follows:
1. Article XIII of the Agreement is hereby redesignated as Article XIV,
and Sections 13.1 through 13.5 are hereby redesignated as Sections 14.1
through 14.5.
2. The Agreement is hereby amended to provide for a new Article XIII,
which contains the following provisions:
"ARTICLE XIII. SHAREHOLDER INFORMATION.
13.1 DEFINITIONS. For purposes of this Article XIII, the following
terms shall have the following meanings:
(a) "INTERMEDIARY" means the Company, on behalf of its separate
accounts investing in the Fund.
(b) "SHARES" means the interests of Contract Owners corresponding to
the redeemable securities of record issued by the Fund under the 1940
Act that are held by the Company on behalf of its separate accounts
investing in the Series of the Fund.
(c) "SHAREHOLDER" means the holder of interests in a Contract with a
beneficial interest in the Fund.
(d) The term "SHAREHOLDER-INITIATED TRANSFER" means a transaction that
is initiated or directed by a Shareholder that results in a transfer
of assets within a Contract to or out of a Series of the Fund, but
does not include transactions that are executed: (1) automatically
pursuant to a contractual or systematic program or enrollment such as
a transfer of assets within a Contract to or out of a Series of the
Fund as a result of "dollar cost averaging" programs or automatic
rebalancing programs; (2) pursuant to a Contract death benefit; (3)
one-time step-up in Contract value pursuant to a Contract death
benefit; (4) allocation of assets to a Series of the Fund through a
Contract as a result of payments such as loan repayments, scheduled
contributions, retirement plan salary reduction contributions, or
planned premium payments to the Contract; (5) pre-arranged transfers
at the conclusion of a required free look period; (6) as a result of
any deduction of charges or fees under a Contract; or (7) within a
Contract out of a Series of the Fund as a result of scheduled
withdrawals or surrenders from a Contract.
(e) "WRITTEN" includes electronic writings and facsimile transmissions.
13.2. AGREEMENT TO PROVIDE INFORMATION. Intermediary will provide the
Fund or its designee, upon written request from the Fund or the Adviser, the
taxpayer identification number ("TIN"), the Individual/International Taxpayer
Identification Number ("ITIN"), or other government-issued identifier ("GII")
and the Contract Owner number or participant account number associated with
the Shareholder, if known, of any or all Shareholder(s) of the account, and
2
the amount, date and transaction type (purchase, redemption, transfer, or
exchange) of every purchase, redemption, transfer, or exchange of Shares held
through an account maintained by the Intermediary during the period covered
by the request. Unless otherwise specifically requested by the Fund, the
Intermediary shall only be required to provide information relating to
Shareholder-Initiated Transfers
13.3. PERIOD COVERED BY REQUEST. Requests must set forth a specific
period, not to exceed 90 days prior to the date of the request, for which
transaction information is sought. The Fund or the Adviser may request
transaction information older than 90 days from the date of the request as it
deems necessary to investigate compliance with policies established by the
Fund or Intermediary for the purpose of eliminating or reducing any dilution
of the value of the outstanding shares issued by the Fund.
13.4. TIMING OF REQUESTS. Requests for Shareholder information shall be
made no more frequently than quarterly except as the Fund or the Adviser deem
necessary to investigate compliance with policies established by the Fund or
Intermediary for the purpose of eliminating or reducing any dilution of the
value of the outstanding shares issued by the Fund.
13.5. FORM AND TIMING OF RESPONSE.
(a) Intermediary will provide, promptly upon request of the Fund or its
designee, the requested information specified in Section 13.2. If requested
by the Fund, the Adviser or their designee, Intermediary will use its best
efforts to determine promptly whether any specific person about whom the Fund
has received the identification and transaction information specified in
Section 13.2 is itself a financial intermediary, as defined in Rule 22c-2
under the 1940 Act (an "indirect intermediary"), and, upon further request of
the Fund, the Adviser or their designee, promptly either (1) provide (or
arrange to have provided) the information set forth in Section 13.2 for those
shareholders who hold an account with the indirect intermediary, or (2)
restrict or prohibit the indirect intermediary from purchasing, in nominee
name on behalf of other persons, securities issued by the Fund. Intermediary
will inform the Fund whether it plans to perform the actions set forth in
subsection (1) or (2).
(b) Responses required by this paragraph must be communicated in
writing and in a format mutually agreed upon by the Fund, the Adviser or
their designee and the Intermediary.
(c) To the extent practicable, the format for any transaction
information provided to the Fund should be consistent with the NSCC
Standardized Data Reporting Format.
3
13.6. LIMITATIONS ON USE OF INFORMATION. The Fund agrees to maintain the
confidentiality of all information received pursuant to this Article XIII and
will not use the information received pursuant to this Article XII for any
purpose other than as necessary to comply with the provisions of Rule 22c-2
under the 1940 Act or to fulfill other regulatory or legal requirements
subject to the privacy provisions of Title V of the Xxxxx-Xxxxx-Xxxxxx Act
(Public Law 106-102) and comparable state laws.
13.7. AGREEMENT TO RESTRICT TRADING. Intermediary will execute written
instructions from the Fund to restrict or prohibit further purchases or
exchanges of Shares by a Shareholder that has been identified by the Fund as
having engaged in transactions of the Fund's shares (directly or indirectly
through the Intermediary's account) that violate policies established by the
Fund or Intermediary for the purpose of eliminating or reducing any dilution
of the value of the then outstanding Shares. Upon receipt of such written
instructions, the Intermediary will:
(1) review the terms of the Contract and Contract prospectus as
well as applicable law to determine the extent of the legal rights
of the Contract Owner to trade into and out of Accounts that
purchase shares of Fund portfolios;
(2) If, upon review, there does not exist any legal or contractual
impediment to restricting or prohibiting trading by the Contract
Owner, then Intermediary will comply with the Fund's request;
(3) If, upon review, there exists a legal or contractual impediment
to restricting or prohibiting trading by the Contract Owner, then
Intermediary will review the availability of any alternatives that
may be implemented to ensure that policies of the Fund established
for the purposes of eliminating or reducing any dilution of the
value of the Shares are not violated. Such alternatives may
include (i) requiring that trades by submitted by the Contract
Owner in writing by mail; (ii) imposition of fees for transfers
between subaccounts as may be permitted under the terms of the
Contract and/or the Contract prospectus; and (iii) limitations on
the total number of trades in a calendar year as permitted under
the terms of the Contract and/or the Contract prospectus. Working
in conjunction with the Fund or its designee, the Company will
implement mutually agreed to measures to achieve the goal of
4
preventing dilution of the value of the Fund's outstanding Shares.
Unless otherwise directed by the Fund, any such restrictions or
prohibitions shall only apply to Shareholder-Initiated Transfers that are
effected directly or indirectly through the Intermediary. Instructions must
be sent to the Intermediary at the following address, or such other address
that the Intermediary may communicate to the Fund in writing from time to
time, including, if applicable, the following e-mail and facsimile number:
Lincoln National Life Insurance Company
Attn: Xxxxxxxx Xxxxxx
0000 X. Xxxxxxx Xxxxxx
Xxxx Xxxxx XX 00000
000-000-0000
xxxxxxx@Xxx.xxx
13.8. FORM OF INSTRUCTIONS. Instructions must include the TIN, ITIN or
GII and the specific individual Contract Owner number or participant account
number associated with the Shareholder, if known, and the specific
restriction(s) to be executed, including how long the restriction(s) is(are)
to remain in place. If the TIN, ITIN, GII or the specific individual
Contract Owner number or participant account number associated with the
Shareholder is not known, the instructions must include an equivalent
identifying number of the Shareholder(s) or account(s) or other agreed upon
information to which the instruction relates. Upon request of the
Intermediary, the Fund will provide to the Intermediary, along with any
written instructions to prohibit further purchases or exchanges of Shares by
the Shareholder, information regarding those trades of the Contract Owner
that violated the policies of the Fund or Intermediary relating to
eliminating or reducing any dilution of the value of the Fund's outstanding
Shares.
13.9. TIMING OF RESPONSE. Intermediary agrees to execute instructions as
soon as reasonably practicable, but not later than ten (10) business days
after receipt of the instructions by the Intermediary.
13.10. CONFIRMATION BY INTERMEDIARY. Intermediary must provide written
confirmation to the Fund that instructions have been executed. Intermediary
agrees to provide confirmation as soon as reasonably practicable, but not
later than ten (10) business days after the instructions have been executed.
13.11. CONSTRUCTION OF THIS ARTICLE XIII. To the extent that the terms of
this Article XIII conflict with the other terms of this Agreement, the terms
of this Article XIII shall control."
5
3. The Agreement is hereby amended to provide for a new Section 14.6,
which contains the following provisions:
"14.6 CUSTOMER IDENTIFICATION. The parties acknowledge that
Federal law requires that the Fund obtain, verify and record information that
identifies each person who opens an account with the Fund, including the
Company on behalf of each Account. In connection with the opening of an
account with the Fund, the Fund will request certain identifying information,
including, but not limited to (1) the name of the account owner, (2) the
address of the account owner's principal place of business, and (3) the
account owner's Taxpayer Identification Number (TIN)."
4. The headings contained in this Amendment are for reference purposes
only and shall not affect in any way the meaning or interpretation of this
Amendment.
5. This Amendment may be executed simultaneously in two or more
counterparts, each of which together shall constitute one and the same
instrument.
6. This Amendment shall be governed by and construed in accordance with
the Laws of the State of
Maryland, without giving effect to the principles of
conflicts of laws.
[SIGNATURE PAGES FOLLOW]
6
IN WITNESS WHEREOF, the parties have caused this Amendment to be duly
executed and delivered by their duly authorized officers, as of the day and
year first above written.
M FUND, INC.
By: /s/ Xxxxxx Xxxxxx
-------------------------
Xxxxxx Xxxxxx, President
M FINANCIAL ADVISERS, INC.
By: /s/ Xxxxxx Xxxxxx
-------------------------
Xxxxxx Xxxxxx, President
THE LINCOLN LIFE & ANNUITY COMPANY OF NEW YORK
By: /s/ Xxxxx X. Xxxxxxxxx
-------------------------
Name: Xxxxx X. Xxxxxxxxx
Title: Second Vice President
7
